Media Mentions
2008
Barbara Jones was mentioned in the September 26 issue of The Boston Business Journal in an article regarding Pro-Pharmaceuticals Inc., the latest biotech company to possibly face a cash crunch. Ms. Jones explained that there has been a significant slow down in the PIPE market this year, which many biotechs rely upon for funding. As a result, companies without commercialized products are finding it more difficult to secure funding than in the past.
Barbara A. Jones, Corporate, Life Sciences & Medical Devices, Private Equity
Den White was quoted on July 23 in PEI Online regarding the latest results of the bi-annual survey of middle market merger professionals by the Association for Corporate Growth (ACG) and Thomson Reuters. "Even though the market has cooled, you still have roughly 90 percent of respondents indicating that the M&A market is good to fair," he said. Mr. White also noted, "We're clearly not in a hot phase but we're clearly not dormant either."
Dennis J. White, Corporate, Mergers & Acquisitions, Private Equity
Thomas Repke, Jeffrey Rothschild and Andrew Shanbrom were mentioned in the July 22 issue of The Deal in an article concerning merger agreements in recent private equity deals. Mr. Repke, Mr. Rothschild and Mr. Shanbrom were cited for their observations in a survey they wrote regarding recent developments in LBO deal terms.
Thomas E. Repke, Jeffrey Rothschild, Andrew Shanbrom, Corporate, Mergers & Acquisitions, Private Equity
Den White was quoted on July 22 by the Business Wire regarding the dissatisfaction of middle market merger professionals with the present M&A market which was concluded by the recent bi-annual survey conducted by the Association for Corporate Growth (ACG) and Thomson Reuters. In the private equity space, respondents see the best investment opportunities in the United States, China, Latin America, India and Eastern Europe. "To an ever-increasing degree buyers and sellers are looking beyond the water's edge for opportunities," said Mr. White. "The U.S. downturn and depressed dollar make everything from New York condos to U.S. companies seem like bargains to foreign buyers. Conversely, U.S. buyers are drawn to the attractive upside opportunities and less competitive investment environment that prevails in many markets overseas. As a result, "cross-border" has become a permanent part of everyone's deal vocabulary."
Dennis J. White, Corporate, Mergers & Acquisitions, Private Equity
Robert A. Schreck was quoted in the July 21 issue of the New York Post in an article regarding the comeback of poison pills. Mr. Schreck commented that he has been counseling his corporate clients to re-evaluate poison pills. He further pointed out that although certain large corporations do not need to worry about takeover threats, midsized companies should remain aware, "...if you're a middle-market company in the striking range of private equity, you should be looking into it," Mr. Schreck said.
Robert A. Schreck PC, Corporate, Mergers & Acquisitions, Private Equity
2007
Peter N. Townshend was quoted on April 24 by Reuters in an article discussing the trend of accelerated negotiations by private equity firms in the mergers and acquisitions market. In an effort to try and beat opponents in the auction process, private equity bidders are giving high offers and securing the deal well before the bidding deadlines. "The question of whether to take an early bid or go through a complete auction is really a game of chicken for both sides," said Mr. Townshend. "If you go through the whole auction, bidders run the risk that others will outbid them. Meanwhile, if the target completes the whole process and the other offers don't turn out as high as they or Wall Street had expected, the company runs the risk that the early, high bid could disappear," Mr. Townshend added.
Peter N. Townshend, Corporate, Mergers & Acquisitions, Private Equity
2006
Howard Steinberg was quoted by Dow Jones on September 28 regarding the banking industry embarking on the private equity market.
Howard E. Steinberg, Corporate, Private Equity
Joel Rubinstein was quoted by Business Week on May 3 in regard to Kohlberg Kravis Roberts & Co. (KKR) listing KKR Private Equity Investors on the Euronext exchange in Amsterdam.
Joel L. Rubinstein, Corporate, Private Equity
Mark Selinger was quoted by Dow Jones MarketWatch on January 6 regarding private equity funds' interest in the technology industry.
Mark S. Selinger, Corporate, Private Equity
2005
Joel Rubinstein was quoted in the November 30 issue of The Wall Street Journal on the Janus Capital Group, Inc. looking at adding a dose of private-equity to pull off a buy-out by its executives and portfolio managers. "There's a general feeling that it's a good time to get into the industry," " The mutual-fund scandals are behind us, hedge funds and all types of investors are looking to invest in the sector. It makes sense for private-equity firms to be there." commented Mr. Rubinstein.
Joel L. Rubinstein, Corporate, Private Equity
McDermott was recommended in Legal 500 European Edition 2005 for the practice area of private equity: "...with Norbert Schulte in Düsseldorf, the firm is developing its real estate private equity portfolio."
Norbert Schulte, Germany, Private Equity, Private Equity/Venture Capital - Germany
Konstantin Günther and Norbert Schulte were mentioned September issue of Juve Rechtsmarkt concerning their advise of Argantis, the joint private equity funds of the German banks IKB Deutsche Industriebank AG and Sal. Oppenheim, on the acquisition of Czewo Full Filling Services Group and the acquisition financing including mezzanine financing by M Cap Deutsche Mezzanine Fonds.
Konstantin Günther, Norbert Schulte, Corporate, Corporate - Germany, Germany, Private Equity, Private Equity/Venture Capital - Germany
Stanley Meadows and Scott Williams were listed in Legal Media Group's latest Expert Guide: Leading Private Equity Lawyers. For more information and a listing of other McDermott lawyers listed in various Expert Guides, visit http://www.legalmediagroup.com/expertguides/default.asp?page=21/.
Stanley H. Meadows PC, Scott M. Williams, Corporate, Private Equity
McDermott was recommended in Der Syndikus - Jahrbuch 2005 -in the practice area of private equity: "Norbert Schulte in the Düsseldorf office advises the real estate private equity portfolio of McDermott."
Norbert Schulte, Germany, Private Equity, Private Equity/Venture Capital - Germany
McDermott Will & Emery was listed as one of the top law firms for M&A, private equity & venture capital in the June issue of Juve azur. The Firm was also mentioned in an article dealing with expected hires for Spring 2005 and 2006 and internships.
Germany, M&A - Germany, Mergers & Acquisitions, Private Equity, Private Equity/Venture Capital - Germany
2004
Joel Rubinstein was quoted in the December 24, 2004 issue of Mass High Tech on Atlas' sale of six life-sciences companies in its portfolio to a Swiss private equity firm. The question being asked: Was this move an example of shrewd dealing, an act of frustration or a little bit of both? The transaction " is not necessarily an indication that these companies are dogs" then commented "They're sitting there with these companies and they need to do something with them." " I can't imagine this is a 'great' event from the limited partners' perspective.", commented Mr. Rubinstein.
Joel L. Rubinstein, Corporate, Private Equity
2002
Andrew Liazos was quoted in the February 21 issue of Private Equity Week in an article addressing recent changes made by the IRS to the tax code dealing with golden parachute payouts. Mr. Liazos commented, "These regulations make it clear that if you have vested stock options and are otherwise not highly compensated, you won’t be subject to the excise tax unless you own more than 1% of the company."
Andrew C. Liazos, Executive Compensation, Private Equity
2001
On December 31, appeared on First Business, a D.C. based television news show.Mr. Sherman discussed entrepreneurship and business growth issues.
Mark Selinger was quoted in the August 13 issue of Private Equity Week in regard to the options that exist for venture capitalists when a "company is drowning." Mr. Selinger addressed the concerns of a new fund bailing out, known as crossover investment.
